Skip to main content

Liawatidewi Yakob's Form 4 filing

Amphastar Pharmaceuticals, Inc. (AMPH) · filed Aug 10, 2022

Accession no.
0001104659-22-088691
Filed
Aug 10, 2022
Trade date
Aug 8-9, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $309.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Liawatidewi YakobCIK 0001743927Officer (EVP Corp Admin Center)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 8, 2022Common StockMOption exerciseAcquired+5,000$19.79+$98,95066,607Direct
Aug 8, 2022Common StockSSaleDisposed−5,000$38.00−$190,00061,607Direct
Aug 9, 2022Common StockMOption exerciseAcquired+3,055$19.79+$60,458.4564,662Direct
Aug 9, 2022Common StockSSaleDisposed−3,055$39.00−$119,14561,607Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 8, 2022Common StockMOption exerciseDisposed−5,000$0.00$03,055Direct
Aug 9, 2022Common StockMOption exerciseDisposed−3,055$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)